… but subject to a joint research agreement as set forth in … other, later-expiring patent. See Gilead Sciences, Inc. v. Natco Pharma Ltd …

… ) $244.99 -2.98% Lam Research Corp. (LRCX) $141.37 -2 … ) $2,093.06 -2.29% Gilead Sciences Inc. (GILD) $121.46 -2 …

… was conducted by researchers from Gilead Sciences, which makes numerous HIV … is apparent in previous research that showed people with … Gilead spokesperson said the research team that presented the … UAB Center for AIDS Research IDWeek Program Chair, HIVMA …

… using both commercial and research-use assays. The median … research support from Roche Diagnostics and Gilead Sciences. Bhagani reported receiving research … funding or support from AbbVie, Gilead Sciences, …

… lead candidate, PP405, stems from research at Dr. William Lowry’s … closely. According to Grand View Research, the global hair-restoration-services … or diseased tissue. Acquired by Gilead Sciences for $4.9 billion, Forty …

… ’t like shots. Lenacapavir, from Gilead Sciences, works differently than other antiretrovirals … dose. Amy Colson, MD, MPH, research director at the Community Resource …

… also abandoned its cell therapy research, in a surprise U-turn … , Gilead Sciences’ Kite Pharma terminated its collaboration with Shoreline, ending a research partnership … fastest-growing areas of pharmaceutical research. According to a September 2025 …

… Andrew Hill, PhD, senior visiting research fellow at the University of … currently manufactured and marketed by Gilead Sciences, Inc. “Lenacapavir is the closest …

… potential autoimmune indications, to fund research and development activities to expand … programs under collaboration agreements with Gilead Sciences, Inc., Sanofi S.A. and …

… immunotherapy. At the same time, Gilead Sciences’ rival TROP2 antibody-drug conjugate … in the journal Clinical Cancer Research, FDA staffers, including Pazdur, suggested …